Skip to content
drillr.ai
Sign up

CUPR

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

NASDAQ · Healthcare · Biotechnology · SG

$3.16
+7.48%
Ask drillr

Income statement

Metric2025202420232022
Revenue
Total Revenue49.9K48.3K100.8K56.6K
Cost of Revenue50.5K51.3K64.2K36.6K
Gross Profit(645.00)(3.0K)36.6K20.0K
Operating Expenses
R&D Expense226.9K241.4K167.7K292.9K
SG&A Expense4.4M1.3M833.4K830.4K
General & Admin Expense4.4M1.3M826.7K790.6K
Selling & Marketing Expense7.9K6.5K6.7K39.7K
Other Expenses(54.5K)131.6K103.8K72.5K
Total Operating Expenses4.6M1.6M1.1M1.2M
Cost and Expenses4.6M1.7M1.2M1.2M
Operating Income (EBIT)(4.6M)(1.6M)(1.1M)(1.2M)
Non-Operating
Interest Income26.6K———
Interest Expense14.7K37.2K56.6K2.0K
Net Interest Income11.8K(37.2K)(56.6K)(2.0K)
Other Non-Op Income/Expense(105.8K)136.7K(17.4K)88.6K
Non-Operating Income (excl Interest)27.8K(173.9K)(39.1K)(90.6K)
EBT (Pre-Tax Income)(4.7M)(1.5M)(1.1M)(1.1M)
Income Tax Expense—51.9K33.8K7.3K
Bottom Line
Net Income(4.7M)(1.6M)(1.1M)(1.1M)
Earnings from Cont. Ops(4.7M)(1.6M)(1.1M)(1.1M)
Earnings from Discont. Ops————
Bottom Line Net Income(4.7M)(1.6M)(1.1M)(1.1M)
Per Share
Basic EPS($1.84)($0.57)($0.41)($0.43)
Diluted EPS($1.84)($0.57)($0.41)($0.43)
Revenue Per Share$0.02$0.02$0.04$0.02
Shares
Basic Shares Outstanding2.6M2.7M2.7M2.6M
Diluted Shares Outstanding2.6M2.7M2.7M2.6M
Profitability Metrics
EBITDA(4.6M)(1.4M)(994.1K)(1.1M)
D&A36.5K42.2K35.1K29.1K
EBIT(4.6M)(1.5M)(1.0M)(1.1M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025